Evidence map›Paper›PMID 35544007›Full record

ArticleExperientia supplementum (2012)2022

Recent Advances with Fish Microsporidia.

Corbin J Schuster, Justin L Sanders, Claire Couch, Michael L Kent

Abstract read
PubMed Publisher
In one paragraph

Article in Experientia supplementum (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Corbin J SchusterDepartment of Microbiology, Oregon State University, Corvallis, OR, USA.
Justin L SandersDepartment of Biomedical Sciences, Oregon State University, Corvallis, OR, USA.
Claire CouchDepartment of Microbiology, Oregon State University, Corvallis, OR, USA.
Michael L KentDepartment of Microbiology, Oregon State University, Corvallis, OR, USA. michael.kent@oregonstate.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There have been several significant new findings regarding Microsporidia of fishes over the last decade. Here we provide an update on new taxa, new hosts and new diseases in captive and wild fishes since 2013. The importance of microsporidiosis continues to increase with the rapid growth of finfish aquaculture and the dramatic increase in the use of zebrafish as a model in biomedical research. In addition to reviewing new taxa and microsporidian diseases, we include discussions on advances with diagnostic methods, impacts of microsporidia on fish beyond morbidity and mortality, novel findings with transmission and invertebrate hosts, and a summary of the phylogenetics of fish microsporidia.

Indexed as

MicrosporidiaMicrosporidiosisAnimalsAquaculturePhylogenyZebrafishDesmozoon lepeophtheriiGlugea anomalaMaternal transmissionMolecular phylogeneticsOvipleistophora diplostomuri

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.